Chelsea Therapeutics

investor header

Analyst Coverage

Corporate Governance

Fundamentals

Snapshot

Current Pricing

Close Price on Jan. 06, 2009	$1.62
52 Week High:	$7.33
52 Week Low:	$1.09
% Change, Last 10 Days	20.9%
% Change, Last 26 Weeks	38.5%
% Change, Last 52 Weeks	-71.3%
Shares Outstanding	30.11 mil.
Avg. Daily Vol. (Last 10 Days)
Price to Revenue Ratio	9.01
Price to Book Ratio	NA

Ratios

Quick Ratio	4.4
Current Ratio	NA
Debt to Equity Ratio	N/A

Annual Income Statement

All amounts are in $Mil except Margins and EPS
	FY End Dec. 2007

Total Revenue	0
Gross Profit	NA
Pretax Income	-15.1
Net Income	-15.1

Institutional Shareholdings

Number Institutions	29
Shares Held (1000s)	13902
Percent Shares Held	46.2%
Last Updated	Nov. 30, 2008

The financial data on this page is provided by CoreData